Condensed Interim Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Cash Flows Used In Operating Activities:
Net loss	$ (1,405,704)	$ (1,400,746)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	44,468	49,309
Share-based compensation	27,039	20,706
Foreign exchange (gain) loss	27,139	17,929
Transfer equipment to research and development	0	10,835
Change in equity investment in joint venture	46,456	0
Changes in working capital items:
Accounts receivable	(30,469)	(9,712)
Inventory	12,188	(50,426)
Prepaid and other assets	(127,916)	(35,919)
Accounts payable and accrued liabilities	17,963	253,561
Deferred revenue	80,000	0
Net cash used in operating activities	(1,308,836)	(1,144,463)
Cash Flows From Investing Activities:
Purchase of property, plant and equipment	(5,666)	(34,767)
Purchase of short-term investments	(21,036)	(4,174)
Proceeds on sales and maturities of short-term investments	4,500,000	1,000,000
Net cash provided by investing activities	4,473,298	961,059
Effect of exchange rate changes on cash and cash equivalents	(25,321)	(17,876)
Net change in cash and cash equivalents	3,139,141	(201,280)
Cash and cash equivalents - beginning of period	4,225,521	4,570,951
Cash and cash equivalents - end of period	7,364,662	4,369,671
Cash (demand deposits)	6,941,818	4,090,861
Cash equivalents	422,844	278,810
Cash and cash equivalents	7,364,662	4,369,671
Supplemental cash flow information:
Cash paid during the period for taxes	$ 0	$ 800